# Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures

> **NCT05292846** · PHASE4 · UNKNOWN · sponsor: **Hospital Universitario La Fe** · enrollment: 200 (estimated)

## Conditions studied

- Coronary Artery Disease
- Bleeding
- Direct Acting Anticoagulant Adverse Reaction

## Interventions

- **DRUG:** Direct-acting oral anticoagulation

## Key facts

- **NCT ID:** NCT05292846
- **Lead sponsor:** Hospital Universitario La Fe
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-20
- **Primary completion:** 2024-02-20
- **Final completion:** 2024-04-20
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05292846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05292846, "Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05292846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*